Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03821597 · ClinicalTrials.gov registry record · NA

Sequential Compression Devices Effect on Fibrinolysis in Plastic Surgery Outpatients

A NA study of Blood Coagulation Disorder, sponsored by Swanson Center.

Completed
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT03821597: Completed NA study of Blood Coagulation Disorder, sponsored by Swanson Center.

NCT03821597 is a NA study of Blood Coagulation Disorder that has completed, run by Swanson Center. The registered enrollment target is 50 participants, below the 472-participant average among 4 other Blood Coagulation Disorder trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03821597, a NA study of Blood Coagulation Disorder, has completed, sponsored by Swanson Center.

COMPLETED
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

This study investigates a possible fibrinolytic effect of sequential compression devices (SCDs). These devices have been used for decades to reduce risk of deep venous thrombosis (DVT). However, a randomized study in plastic surgery outpatients has not been done. This study is undertaken to remedy that deficiency in our knowledge base.

Conditions Studied

Interventions

  • PROCEDURE Sequential compression devices (SCDs)
  • PROCEDURE No sequential compression.

Study Locations (1)

Kansas

  • Swanson Center - Leawood

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2018-11-01
Est. Completion 2019-01-27
Phase NA

Sponsor

Swanson Center

3 total trials

What the Registry Record Tells You About NCT03821597

The ClinicalTrials.gov registry entry for NCT03821597 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 472-participant average among 4 other Blood Coagulation Disorder trials with a reported enrollment target (89% lower). The listed sponsor is Swanson Center, which has 3 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Blood Coagulation Disorder appearing as the primary indexed condition, and to 2 interventions - of which Sequential compression devices (SCDs) is the first listed.

NCT03821597 reports 1 study location spanning 1 distinct geographic area - top geographies include Kansas.

Frequently Asked Questions

What is clinical trial NCT03821597 about?

NCT03821597 is a clinical study titled "Sequential Compression Devices Effect on Fibrinolysis in Plastic Surgery Outpatients". This study investigates a possible fibrinolytic effect of sequential compression devices (SCDs). These devices have been used for decades to reduce risk of deep venous thrombosis (DVT). However, a randomized study in plastic surgery outpatients has not been done. This study is undertaken to remedy t...

What is the current status of trial NCT03821597?

This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2018-11-01. Estimated completion is 2019-01-27.

What conditions does trial NCT03821597 study?

This clinical trial studies the following conditions: Blood Coagulation Disorder.

What interventions are being tested in trial NCT03821597?

The interventions under investigation include: Sequential compression devices (SCDs) (PROCEDURE), No sequential compression. (PROCEDURE).

Who is sponsoring clinical trial NCT03821597?

This trial is sponsored by Swanson Center, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03821597 being conducted?

This trial has 1 study location across Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Blood Coagulation Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.